Biomea Fusion BMEA
NASDAQ BMEA
$0.58 +0.03 (+5.96%)
As of: Nov 11, 2026 · 11:18 AM EST

Biomea Fusion (BMEA) Other Non Operating Income (2025 - 2026)

Updated

Biomea Fusion (BMEA) recorded Other Non Operating Income of -$4.12 million in Q2 2026, compared with -$227,000 a year earlier.

Analysis

Biomea Fusion (BMEA) Other Non Operating Income (2025 - 2026) Analysis & Trends

For FY2025, Biomea Fusion reported Other Non Operating Income of -$19.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Biomea Fusion 39.97 Mn -121.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -6.51 Mn
Jun 30, 2026 -4.12 Mn
Mar 31, 2026 600,000.00
Dec 31, 2025 -15.80 Mn
Sep 30, 2025 -3.87 Mn
Jun 30, 2025 -227,000.00
API Access

Biomea Fusion Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=BMEA&period=max&api_key=YOUR_API_KEY